GlaxoSmithKline Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on November 06, 2014, inter alia, to consider & approval of unaudited financial results for the quarter ended September 30, 2014 (Q3).

Source : BSE - >www.bseindia.com

comment COMMENT NOW